Cardioprotective effect of semaglutide are independent of adiposity and weight

Paper title: Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

Interpretation The cardioprotective effects of semaglutide were independent of baseline adiposity and weight loss and had only a small association with waist circumference, suggesting some mechanisms for benefit beyond adiposity reduction.

(Funded by Novo nordisk)

Found via https://archive.is/URt7Y (the australian)